Aller au contenu principal
Fermer
  2. Aide
  2. Aide

BIOPHYTIS ANNOUNCES COMPLETION OF OVER €2.0 MILLION CAPITAL INCREASE AND THE REPAYMENT OF ALL VARIABLE PRICE CONVERTIBLE DEBT
information fournie par Boursorama CP 11/03/2026 à 07:30
Ajoutez Boursorama à vos sources préférées

Paris (France) and Cambridge (Massachusetts, United States), March 11, 2026 at 7.30 AM (CET) –
Biophytis SA (Euronext Growth Paris : ALBPS), (“Biophytis” or the “Company”), a pioneer in the development of transformative therapies impacting longevity, today announces the completion of a capital increase trough the issue of new shares each accompanied by a share subscription warrant, with the removal of the preferential subscription rights of the Company’s existing shareholders in favor of several institutional investors, for a total gross amount of €2,015,000 (the “Issue”). This capital increase was subscribed by a limited number of investors including Alumni Capital for €1,250,000 and Hexagon Capital Fund for €300,000.

Valeurs associées

BIOPHYTIS
0,0153 EUR Euronext Paris 0,00%

0 commentaire

Signaler le commentaire

Fermer

A lire aussi

Mes listes

valeur

dernier

var.
Pétrole Brent
98,4 -2,61%
CAC 40
8 372,28 +0,88%
TOTALENERGIES
75,9 -0,37%
Or
4 055,93 0,00%
2CRSI
27,58 +4,08%
Chargement...

Pages les plus populaires

L'offre BoursoBank